AMRI, PerkinElmer to Collaborate on Drug Discovery
News Jun 18, 2015
The new AMRI center is part of the Buffalo Medical Innovation and Commercialization Hub (BMIC), a public-private pharmaceutical research and development initiative in Buffalo, New York. The Hub is a collaborative effort that involves SUNY Polytechnic Institute and the State of New York, AMRI, and other industry partners that provide services, platforms, and expertise needed to support drug development projects in academia and industry.
As a result of its collaboration with PerkinElmer, scientists at the BMIC hub will have access to AMRI's chemistry and biology expertise, and they will have access PerkinElmer's informatics technologies and high-content screening capabilities, as well as its cellular imaging and analytics instruments. PerkinElmer will also provide technical and informatics experts to facilitate technological and drug discovery innovations.
"We are pleased to have the opportunity to deliver the platforms, informatics technologies and services to AMRI for its new center of excellence for drug discovery and translational research," Jim Corbett, PerkinElmer's president, human health, said in a statement. "We look forward to supporting the BMIC's expansion by working closely with additional companies that establish lab facilities at this site."
Changing Lanes: Algorithm Helps AI Drive More Like HumansNews
For self-driving cars, algorithms for changing lanes are beset by one of two problems. Either, they rely on detailed statistical models of the driving environment, which are too complex to analyze on the fly; or they’re so simple that they can lead to impractically conservative decisions, such as never changing lanes at all. Now a new algorithm hopes to split the difference, allowing aggressive lane changes than the simple models do but relies only on immediate information about other vehicles’ directions and velocities to make decisions.
Antitumor Immune Function in Liver Controlled by Gut MicrobiomeNews
Scientists have found a connection between bacteria in the gut and antitumor immune responses in the liver. The study showed that bacteria found in the gut of mice affect the liver’s antitumor immune function. The findings have implications for understanding the mechanisms that lead to liver cancer and for therapeutic approaches to treat them.READ MORE
Tiny Particles Carry Tumor Shrinking Drugs into the BrainNews
MIT researchers have now devised a new drug-delivering nanoparticle that could offer a better way to treat glioblastoma. The particles, which carry two different drugs, are designed so that they can easily cross the blood-brain barrier and bind directly to tumor cells.READ MORE
Comments | 0 ADD COMMENT
2nd Annual Artificial Intelligence in Drug Development Congress
Sep 20 - Sep 21, 2018